| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | See Remarks
2 companies
Shook David serves as a See Remarks at NKTX and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 0 buys and 6 sells. Those positions are worth an estimated $771K at current prices.
Historically, Shook David's trades have earned a middling insider score of 53/100 across 6 rated trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of -4.0%.
The biggest single holding is NKTX (~$445K) as See Remarks. The recent filings there lean toward selling, a net 14,591 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 15, 2025 | NKTX Nkarta, Inc. | See Remarks | Sell | 8,638 | $2.20 | $19,003.60 | -4.3% | -23.7% | -12.5% | |
| Jun 18, 2024 | NKTX Nkarta, Inc. | Chief Medical Officer | Sell | 456 | $5.60 | $2,553.60 | -0.4% | +7.2% | -65.5% | |
| Jan 16, 2024 | NKTX Nkarta, Inc. | Chief Medical Officer | Sell | 3,552 | $8.74 | $31,044.48 | -3.0% | +0.5% | -74.2% | |
| Aug 21, 2023 | NKTX Nkarta, Inc. | Chief Medical Officer | Sell | 1,331 | $1.83 | $2,435.73 | -2.2% | +43.7% | +180.8% | |
| Jun 20, 2023 | NKTX Nkarta, Inc. | Chief Medical Officer | Sell | 439 | $4.85 | $2,129.15 | -0.7% | -67.1% | +8.7% | |
| Jan 17, 2023 | NKTX Nkarta, Inc. | Chief Medical Officer | Sell | 175 | $5.49 | $960.75 | -0.3% | -14.2% | +67.2% |